Q3 earnings report: SOLV beats estimates with clear results
Q3 earnings report shows SOLV beating estimates despite revenue decline.
Precigen earnings report: Proven revenue beats estimates
Precigen earnings report reveals a $0.03 beat and revenue surpassing expectations, indicating strong performance in the market.
Xylem Q3 earnings show disappointing results amid challenges
Xylem Q3 earnings reveal a miss on estimates due to soft performance.